NRX Pharmaceuticals Warrant
NRXPW
NRXPW was delisted on the 22nd of May, 2026.
4 hedge funds and large institutions have $4.46M invested in NRX Pharmaceuticals Warrant in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
84,097% more capital invested
Capital invested by funds: $5.3K → $4.46M (+$4.45M)
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
33% more funds holding
Funds holding: 3 → 4 (+1)
0.43% less ownership
Funds ownership: 0.43% → 0% (-0.43%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BGI
B Group Inc
Dallas,
Texas
|
+$255K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.58K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Truist Financial
Charlotte,
North Carolina
|
-$3.32K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$126 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BGI
1
B Group Inc
Dallas,
Texas
| $4.46M | +$255K | +3,000,000 | New |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $3.37K | +$3.58K | +42,167 | New |
|
|
WAM
3
Wolverine Asset Management
Chicago,
Illinois
| $1.55K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $1 | -$126 | -1,482 | -99% |
|
|
5
Truist Financial
Charlotte,
North Carolina
| – | -$3.32K | -38,965 | Closed |
|
NRXPW Hedge Fund Activity: Q3 2025 in Review
4 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in NRX Pharmaceuticals Warrant (NRXPW) for Q3 2025, worth a combined $4.46M — up 84,097% from $5.3K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new NRXPW positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was B Group Inc, opening a new position worth an estimated $255K. The largest seller was Truist Financial, exiting entirely with an estimated $3.32K sold.
- 4 institutional investors held NRX Pharmaceuticals Warrant (NRXPW) as of Q3 2025, up from 3 in Q2 2025.
- Funds reported $4.46M of NRX Pharmaceuticals Warrant stock for Q3 2025, up 84,097% quarter-over-quarter.
- 2 funds opened new NRX Pharmaceuticals Warrant positions in Q3 2025 and 1 closed out, a net change of +1 holder.
- The largest NRX Pharmaceuticals Warrant buyer in Q3 2025 was B Group Inc, an estimated $255K added.
- The largest NRX Pharmaceuticals Warrant seller in Q3 2025 was Truist Financial, an estimated $3.32K sold.
Based on aggregated 13F filings for Q3 2025.